<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001924'>Sideroblastic anemia</z:hpo> is characterized by <z:hpo ids='HP_0001903'>anemia</z:hpo> with the emergence of ring sideroblasts in the bone marrow </plain></SENT>
<SENT sid="1" pm="."><plain>There are two forms of <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>, i.e., congenital <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> (CSA) and acquired <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In order to clarify the pathophysiology of <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>, a nationwide survey consisting of clinical and molecular genetic analysis was performed in Japan </plain></SENT>
<SENT sid="3" pm="."><plain>As of January 31, 2012, data of 137 cases of <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo>, including 72 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)-refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>), 47 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with ring sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), and 18 cases of CSA, have been collected </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> and MCV level in CSA are significantly lower than those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, whereas serum iron level in CSA is significantly higher than those of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Of 14 CSA for which DNA was available for genetic analysis, 10 cases were diagnosed as <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:hpo ids='HP_0001924'>sideroblastic anemia</z:hpo> due to ALAS2 gene mutation </plain></SENT>
<SENT sid="6" pm="."><plain>The mutation of SF3B1 gene, which was frequently mutated in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RS, was not detected in CSA patients </plain></SENT>
<SENT sid="7" pm="."><plain>Together with the difference of clinical data, it is suggested that genetic background, which is responsible for the development of CSA, is different from that of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-RS </plain></SENT>
</text></document>